GC‑MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets
In Silico Pharmacology · 07.05.2026 · 14 (2)
DOI: 10.1007/s40203-026-00634-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 07.05.2026. Verfasst von Venkat Loshni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Thandalam, Chennai, Tamil…. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Thandalam, Chennai, Tamil Nadu 602105 India.
- Molecular Biology and Genomics Lab, Department of Orthopaedics, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Thandalam, Chennai, Tamil Nadu…
ORCID-Profile: Raju Balaji
Zitieren
APA
Loshni, V., Lakshmi, T., & Balaji, R. (2026). GC‑MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets. In Silico Pharmacology, 14(2). https://doi.org/10.1007/s40203-026-00634-3
Vancouver
Loshni V, Lakshmi T, Balaji R. GC‑MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets. In Silico Pharmacology. 2026;14(2). doi:10.1007/s40203-026-00634-3
BibTeX
@article{Loshni2026,
author = {Loshni, Venkat and Lakshmi, Thangavelu and Balaji, Raju},
title = {GC‑MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {2},
doi = {10.1007/s40203-026-00634-3}
}
EUVIMED